CliffBio
small molecule

HECTOROL

DOXERCALCIFEROL

Loss of exclusivity—loss of exclusivity
CompanySanofi Genzyme →See this company's full patent-cliff portfolio

Drug detail

Brand nameHECTOROL
Active ingredientDOXERCALCIFEROL
Strength2MCG/ML (2MCG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalApril 2000
Marketing statusDISCN

More from Sanofi Genzyme

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

HECTOROL patent cliff — loss of exclusivity — | CliffBio